Detalles de la búsqueda
1.
Safety and efficacy of bimekizumab through 2 years in patients with moderate-to-severe plaque psoriasis: longer-term results from the BE SURE randomized controlled trial and the open-label extension from the BE BRIGHT trial.
Br J Dermatol;
188(1): 22-31, 2023 01 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36689515
2.
Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study.
Br J Dermatol;
189(4): 392-399, 2023 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37279795
3.
Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials.
JAMA;
328(11): 1073-1084, 2022 09 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36125472
4.
Efficacy and safety of topical terbinafine 10% solution (MOB-015) in the treatment of mild to moderate distal subungual onychomycosis: A randomized, multicenter, double-blind, vehicle-controlled phase 3 study.
J Am Acad Dermatol;
85(1): 95-104, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32585278
5.
Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trial.
J Am Acad Dermatol;
82(6): 1314-1320, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32007513
6.
Long-term efficacy and safety of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Post hoc pediatric subgroup analysis from a 44-week open-label extension study.
Pediatr Dermatol;
37(3): 490-497, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32147881
7.
Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials.
J Am Acad Dermatol;
80(1): 128-138.e2, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30003988
8.
Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate and Severe Acne Vulgaris in Females: Effect of Age on Efficacy and Tolerability
J Drugs Dermatol;
18(12): 1218-1225, 2019 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31860209
9.
Efficacy of Dupilumab in Different Racial Subgroups of Adults With Moderate-to-Severe Atopic Dermatitis in Three Randomized, Placebo-Controlled Phase 3 Trials
J Drugs Dermatol;
18(8): 804-813, 2019 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31424712
10.
Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials.
Pediatr Dermatol;
36(1): 89-99, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30451318
11.
Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients.
BMC Cancer;
18(1): 130, 2018 02 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29402264
12.
Efficacy and safety of roflumilast cream for chronic plaque psoriasis with facial/neck and intertriginous area involvement: a post hoc analysis from a randomized controlled trial.
Br J Dermatol;
188(6): 810-812, 2023 05 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36890712
13.
Safety and efficacy of a fixed combination of halobetasol and tazarotene in the treatment of moderate-to-severe plaque psoriasis: Results of 2 phase 3 randomized controlled trials.
J Am Acad Dermatol;
79(2): 287-293, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29614243
14.
Halobetasol 0.01%/Tazarotene 0.045% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Maintenance of Therapeutic Effect After Cessation of Therapy.
J Drugs Dermatol;
17(7): 723-726, 2018 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30005093
15.
Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Assessment of Efficacy and Safety in Patients Aged 9 Years and Older.
J Drugs Dermatol;
17(10): 1084-1091, 2018 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30365589
16.
Planimetric Post-hoc Analysis of Women With Onychomycosis from Tavaborole 5% Phase III Studies: Evidence of Greater Improvements in Patients With >50% Baseline Infection.
J Drugs Dermatol;
17(2): 168-172, 2018 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29462224
17.
From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis.
J Am Acad Dermatol;
76(2): 290-298, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27908543
18.
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of a Halobetasol/Tazarotene Fixed Combination in the Treatment of Plaque Psoriasis.
J Drugs Dermatol;
16(3): 197-204, 2017 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28301614
19.
Randomized, Placebo- and Active-Controlled Crossover Study of the Safety and Efficacy of THVD-102, a Fixed-dose Combination of Oxybutynin and Pilocarpine, in Subjects With Primary Focal Hyperhidrosis.
J Drugs Dermatol;
16(2): 127-132, 2017 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28300854
20.
Safety and Efficacy of Escalating Doses of Ingenol Mebutate for Field Treatment of Actinic Keratosis on the Full Face, Full Balding Scalp, or Chest.
J Drugs Dermatol;
16(5): 438-444, 2017 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28628679